Publications by authors named "John Flack"

Claim this Profile

Mentions over time

Mentions by platform

Video Views

109,724

Total Likes

2,767

Extended Reach

3,737,215

Social Features

142
E
Effects of aprocitentan on prognostically relevant ambulatory blood pressure-derived variables in resistant hypertension.
Markus P Schlaich, Michael A Weber, John M Flack, Parisa Danaietash, Mouna Sassi-Sayadi

J Hypertens· January 2026

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Carbon Dioxide Angiography-Guided Ultrasound Renal Denervation in Refractory Hypertension With Chronic Kidney Disease.
Mohamad Bahrou, Ahmed Shahab, Rami Al-Ayyubi, John Flack, Abdul Moiz Hafiz

JACC Case Rep· January 2026

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Aprocitentan in Patients With Chronic Kidney Disease and Resistant Hypertension.
Patrick Rossignol, Martine Clozel, Roland F Dreier, John M Flack, Bruno Flamion

Hypertension· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Baxdrostat for uncontrolled and resistant hypertension: rationale and design of the Phase 3 clinical trials BaxHTN, BaxAsia, and Bax24.
John M Flack, Michel Azizi, Jenifer M Brown, Jamie P Dwyer, Erika S W Jones

Hypertens Res· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Expanding the Search for Primary Aldosteronism in Clinical Settings.
John M Flack, Michael G Buhnerkempe, Garry L R Jennings

Hypertension· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Blood Pressure-Elevating and Antihypertensive Medication Prescription Trends.
Ashutosh Kumar, Nicole L Therrien, John I Ogwuegbu, Jun Soo Lee, Hilary K Wall, John M Flack

Hypertension· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Lorundrostat Efficacy and Safety in Patients with Uncontrolled Hypertension.
Luke J Laffin, Branko Kopjar, Carrie Melgaard, Kathy Wolski, Jessica Ibbitson, John M Flack

N Engl J Med· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Aprocitentan for Blood Pressure Reduction in Black Patients.
John M Flack, Markus P Schlaich, Michael A Weber, Mouna Sassi-Sayadi, Krzysztof Narkiewicz

Hypertension· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Misconceptions and Facts About Orthostatic Hypotension.
Chayakrit Krittanawong, Affan Rizwan, Aryan Rezvani, Muzamil Khawaja, Mario Rodriguez, John M Flack

Am J Med· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evolving the Role of Black Race in Hypertension Therapeutics.
John M Flack, Stephanie Bitner, Michael Buhnerkempe

Am J Hypertens· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Editorial commentary: Highlighting important (selected) issues in hypertension therapeutics.
John M Flack, Stephanie Bitner, Michael Buhnerkempe

Trends Cardiovasc Med· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Management of Elevated Blood Pressure in the Acute Care Setting: A Scientific Statement From the American Heart Association.
Adam P Bress, Timothy S Anderson, John M Flack, Lama Ghazi, Michael E Hall

Hypertension· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Sacubitril/Valsartan as an Effective Hypertension Treatment Option in Those With Chronic Type B Aortic Dissection.
Michael G Buhnerkempe, Stephanie Bitner, John M Flack

Am J Hypertens· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Resistant Hypertension: Disease Burden and Emerging Treatment Options.
John M Flack, Michael G Buhnerkempe, Kenneth Todd Moore

Curr Hypertens Rep· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Orthostatic Hypotension in Adults With Hypertension: A Scientific Statement From the American Heart Association.
Stephen P Juraschek, Melissa M Cortez, John M Flack, Lama Ghazi, Rose Anne Kenny

Hypertension· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Finerenone in Black Patients With Type 2 Diabetes and CKD: A Post hoc Analysis of the Pooled FIDELIO-DKD and FIGARO-DKD Trials.
John M Flack, Rajiv Agarwal, Stefan D Anker, Bertram Pitt, Luis M Ruilope

Kidney Med· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Editors' Commentary on the 2023 ESH Management of Arterial Hypertension Guidelines.
Paul K Whelton, John M Flack, Garry Jennings, Alta Schutte, Jiguang Wang

Hypertension· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical Outcomes in Hypertensive Emergency: A Systematic Review and Meta-Analysis.
Tariq Jamal Siddiqi, Muhammad Shariq Usman, Ahmed Mustafa Rashid, Syed Sarmad Javaid, Aymen Ahmed, John M Flack

J Am Heart Assoc· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
International Consensus on Standardized Clinic Blood Pressure Measurement - A Call to Action.
Alfred K Cheung, Paul K Whelton, Paul Muntner, Aletta E Schutte, Andrew E Moran, John M Flack

Am J Med· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Therapeutic Nihilism in Older Hypertensives: A Resounding Call to Action.
John M Flack, Asad Cheema

Hypertension· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Endovascular Ultrasound Renal Denervation to Treat Hypertension: The RADIANCE II Randomized Clinical Trial.
Michel Azizi, Manish Saxena, Yale Wang, J Stephen Jenkins, Chandan Devireddy, John Flack

JAMA· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Does Vitamin D Provide Added Benefit to Antihypertensive Therapy in Reducing Left Ventricular Hypertrophy Determined by Cardiac Magnetic Resonance?
Phillip D Levy, Michael J Twiner, Aaron M Brody, Rachelle Dawood, Brian Reed, John M Flack

Am J Hypertens· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Association of Vitamin K Status with Arterial Calcification and Stiffness in Chronic Kidney Disease: The Chronic Renal Insufficiency Cohort.
M Kyla Shea, Jifan Wang, Kathryn Barger, Daniel E Weiner, Raymond R Townsend, John Flack

Curr Dev Nutr· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dual endothelin antagonist aprocitentan for resistant hypertension (PRECISION): a multicentre, blinded, randomised, parallel-group, phase 3 trial.
Markus P Schlaich, Marc Bellet, Michael A Weber, Parisa Danaietash, George L Bakris, John M Flack

Lancet· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis